199P Real-world outcomes in clear cell gynaecological malignancies: The impact of endometriosis at two London tertiary centres

B. Anderson, H. Cheney Lowe, H. Lowe, H.A. Hockings, E. Tsotra, R. Miller, R. Kristeleit
In: ESMO Open · 2026 · vol. 11 , pp. 108137 · doi:10.1016/j.esmoop.2026.108137 · W7167026526
article OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-13 ⓘ

This study evaluated real-world outcomes of clear cell gynaecological cancers, investigating the impact of endometriosis at two London tertiary centers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Clear cell gynaecological cancers (CCGC) are rare, biologically distinct and often chemo-resistant with poor prognosis in advanced stages. Endometriosis is a well-recognised precursor, yet its impact on CCGC behaviour is unclear. We performed a retrospective dual-centre analysis to evaluate real-world outcomes.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-30T06:08:52.026869+00:00
License: CC0 · commercial use OK